Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Compact Ultralow Temperature Storage Solutions Available

By BiotechDaily International staff writers
Posted on 01 Jun 2014
Image: The Hamilton BIOS M Ultra-low Temperature Storage System (Photo courtesy of Hamilton Storage Technologies).
Image: The Hamilton BIOS M Ultra-low Temperature Storage System (Photo courtesy of Hamilton Storage Technologies).
A line of advanced deep freezers with robotic sample access is now available for biotech and life science laboratories.

The Hamilton Storage Technologies (Franklin, MA, USA) BiOS M and L are two compact high-density systems for the ultralow-temperature storage of sensitive biological samples.

All samples within the BiOS systems are stored in -80 degrees Celsius chest freezer compartments to maintain temperature stability. All internal workflows, including sample picking, are optimized to keep samples at ultralow temperatures at all times. System parts are easily accessible for service and maintenance, while one-dimensional and two-dimensional barcode reading and sample tracking provide complete chain-of-custody documentation—a requirement for forensic laboratories. Multiple backup systems ensure that samples stay at -80 degrees Celsius in the event of power failure.

“By adding smaller configurations of our high-capacity BiOS -80 degree Celsius storage system, more labs have access to state-of-the-art sample storage within steps of their sample preparation and analysis stations,” said Dr. Martin Frey, PhD, head of Hamilton Storage Technologies. “This reduces the likelihood that results may be compromised.”

Related Links:
Hamilton Storage Technologies



comments powered by Disqus

Channels

Drug Discovery

view channel
Image: The European Commission has approved the use of Avastin combined with chemotherapy as a treatment for women with recurrent ovarian cancer (Photo courtesy of Genentech).

Drug for Treatment of Platinum Resistant Recurrent Ovarian Cancer Approved for Use in Europe

For the first time in more than 15 years the European Commission (EC) has approved a new therapeutic option for the most difficult to treat form of ovarian cancer. Ovarian cancer causes more deaths... Read more

Therapeutics

view channel
Image: This type of electronic pacemaker could become obsolete if induction of biological pacemaker cells by gene therapy proves successful (Photo courtesy of Wikimedia Commons).

Gene Therapy Induces Functional Pacemaker Cells in Pig Heart Failure Model

Cardiovascular disease researchers working with a porcine heart failure model have demonstrated the practicality of using gene therapy to replace implanted electronic pacemakers to regulate heartbeat.... Read more

Business

view channel

Global Computational Biology Sector Expected to Reach over USD 4 Billion by 2020

The global market for computational biology is expected to reach USD 4.285 billion by 2020 growing at a compound annual growth rate (CAGR) of 21.1%, according to new market research. Steady surge in the usage and application of computational biology for bioinformatics R&D programs designed for sequencing genomes... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.